Oncolytic Virus-Based Immunotherapies for Hepatocellular Carcinoma

Hepatocellular carcinoma is highly refractory cancer which is resistant to conventional chemotherapy and radiotherapy, carrying a dismal prognosis. Although many anticancer drugs have been developed for treating HCC, sorafenib is the only effective treatment, but it only prolongs survival duration f...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoo, So Young, Badrinath, Narayanasamy, Woo, Hyun Young, Heo, Jeong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5415860/
https://www.ncbi.nlm.nih.gov/pubmed/28512387
http://dx.doi.org/10.1155/2017/5198798

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5415860/
https://www.ncbi.nlm.nih.gov/pubmed/28512387
http://dx.doi.org/10.1155/2017/5198798

Ejemplares similares